Cannabis Research
Stay abreast of cutting-edge cannabis research. Dive into studies, understand the science behind terpenes, CBD, and THC, and contribute to an informed dialogue.
492 topics in this forum
-
-
- 420 Crew
- 3 replies
- 1.3k views
Tampa Bay Online Sanofi-Aventis, Pfizer End Studies on Diet Drugs LINDA A. JOHNSON, AP Business Writer, TRENTON, N.J. French drugmaker Sanofi-Aventis said Wednesday it is halting all research on a diet drug sold in Europe, Acomplia, and rival Pfizer Inc. hours later said it is ending research on an experimental weight-loss drug in the same class. Both drugs work by blocking the pleasure centers that give marijuana smokers the "munchies" - the cannabinoid type 1, or CB1, receptors. Given that obesity and related complications are arguably the world's biggest public health problem, the demise of both drugs will be a big disappointment for patients and doctors, and possibl…
-
-
- 0 replies
- 924 views
High Expectations Research into medicinal marijuana grows up. By Amanda Schaffer Posted Thursday, Nov. 6, 2008 Slate.com http://www.slate.com/id/2203922/ This summer, British and Italian researchers found that in a laboratory plate, molecules in marijuana can slay the superbug methicillin-resistant staphylococcus aureus, which recently infected seven babies and four employees in a Yonkers, N.Y., maternity ward, heightening fears of outbreaks in schools and locker rooms, as well as in its more familiar breeding grounds, hospitals and nursing homes. In theory, compounds derived from the cannabis plant could someday serve in topical creams for patients with MRSA or other a…
Last reply by grace, -
-
- 420 Crew
- 1 reply
- 977 views
Cannabis use by people with severe mental illness – is it important? Zerrin Atakan Advances in Psychiatric Treatment (2008) 14: 423-431. doi: 10.1192/apt.bp.105.002006 © 2008 The Royal College of Psychiatrists http://apt.rcpsych.org/cgi/content/abstract/14/6/423 Zerrin Atakan worked as the lead consultant in the National Psychosis Unit at the Maudsley & Bethlem Royal Hospitals in London until August 2007, when she retired from NHS duties. She currently holds an honorary contract at the Institute of Psychiatry (De Crespigny Park, London SE5 8AF, UK; email: Zerrin.Atakan@iop.kcl.ac.uk), where she is doing research on the effects of cannabis compounds on brain functio…
Last reply by Frazz, -
-
- 1 reply
- 792 views
New Report Analyses the Market for Cannabinoid Products Live-PR Public Relations and News 31 October 2008 http://www.live-pr.com/en/new-report-analy...r1048214933.htm Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report providing a critical examination of current cannabinoid products and areas of unmet clinical need where the use of cannabinoids could be clinically beneficial and commercially profitable. (live-PR.com) - “Emerging Opportunities with Cannabinoids” which is available at www.piribo.com/search/results.html?k=ESP1105 reports that the psychotropic effects of Cannabis have been known for…
Last reply by Dragonfan, -
- 0 replies
- 728 views
Effects of cannabis use on outcomes of psychotic disorders: systematic review (Abstract) The British Journal of Psychiatry (2008) 193: 357-363. doi: 10.1192/bjp.bp.107.046375 © 2008 The Royal College of Psychiatrists http://bjp.rcpsych.org/cgi/content/abstract/193/5/357 Stanley Zammit, PhD Academic Unit of Psychiatry, University of Bristol, and Department of Psychological Medicine, Cardiff University Theresa H. M. Moore, MSc, BSc and Anne Lingford-Hughes, BM, BCh, PhD [/b] Academic Unit of Psychiatry, University of Bristol Thomas R. E. Barnes, MD, DSc Department of Psychological Medicine, Imperial College London Peter B. Jones, MD, PhD Department of Ps…
Last reply by grace, -
- 0 replies
- 885 views
Risk factors and outcome in psychosis Sukhwinder S. Shergill The British Journal of Psychiatry (2008) 193: A18. doi: 10.1192/bjp.193.5.A18 © 2008 The Royal College of Psychiatrists http://bjp.rcpsych.org/cgi/content/full/193/5/A18 The population prevalence of intellectual disability (also known as learning disability in UK health services) is approximately 1%, rather similar to the estimate of lifetime population risk for schizophrenia. The risk of psychiatric illness, particularly schizophrenia, is thought to be increased in people with intellectual disability. Morgan et al (pp. 364–372) linked two large population-based case registers in Australia to examine the over…
Last reply by grace, -
-
- 420 Crew
- 25 replies
- 4.2k views
Dynamic Alert Negotiates With Medical Cannabis Research & Development Firm and Appoints Former CEO of NORML, Richard Cowan as Director & CEO Sept. 19, 2008 The Wall Street Journal - Market Watch http://www.marketwatch.com/news/story/dyna...D&dist=hppr Dynamic Alert Limited is pleased to announce that it has appointed Richard Cowan as Director, President and CEO, in the place of Audrey Reich who has resigned. Mr. Cowan has been retained to facilitate the Company entering into the rapidly expanding medical cannabis research and development industry. Cowan's valuable experience, knowledge, and relationships will be instrumental with completing negotiations with…
-
-
- 0 replies
- 894 views
Found this article whilst surfing the net, Its fairly old, but still a interesting read none the less. In particular for people who don't know much about how marijuana affects the body/brain and addiction vs tolerance stuff. http://www.ukcia.org/research/gettman3.htm THE TLDR version for people that can't be bothered clicking the link or reading the entire thing: Cannabis works differently than most other drugs. Most hard drugs, and common drugs etc, ie: Cocaine, Heroin, amphetamines, Alcohol, Tobbaco etc work by adjusting the dopamine levels in your body, which gives you that high/pleasurable feeling, although most often, with extended use, your body naturally re…
Last reply by Wrangler556, -
- 0 replies
- 711 views
ScienceDaily Protecting Brain Cells From Diseases Like Alzheimer's Using New Method ScienceDaily (Aug. 22, 2008)
Last reply by Dragonfan, -
- 0 replies
- 941 views
Researchers explore marijuana and mental health 8 October 2008 physorg.com http://www.physorg.com/news142694179.html A team of mental health experts from the University of Western Sydney say young people who have developed a dependence on cannabis are likely to continue using the drug following the diagnosis of a mental illness. To find out their reasons why, the Social Justice Social Change Research Centre (SJSC) at UWS will commence a study of the links between marijuana and mental health in 2009. Cannabis is one of the most widely used drugs in the world. In Australia, forty to fifty percent of young people admit to trying cannabis at least once. Associate Pr…
Last reply by grace, -
- 20 replies
- 7.9k views
How to improve the quality of the high from a low quality bud - the magic of Terpenes While I was in Nimbin recently at the 2008 Mardi Grass, I had the opportunity to sit and blow a joint with Ed Rosenthal. We got to talking about Terpenes, with particular regard to a chapter in Ed's latest Book, "The Big Book of Buds Vol. 3", called 'The Secret Chemistry of Cannabis Odors and Highs'. The discussion led to a Terpene known as Myrcene, which is the most prevalent Terpene found in most varieties of Cannabis, but not found in hemp. It is also present in high amounts in mangos, hops, lemon grass, West Indian bay tree, verbena and the plant from which it derives it's name Me…
Last reply by Smokin Moose, -
- 3 replies
- 1.2k views
NORML September 12th, 2008 By: Allen St. Pierre, NORML Executive Director www.pubmed.gov
Last reply by entheofarm, -
- 0 replies
- 1k views
Cannabis and the Course of Schizophrenia DANIELE FABIO ZULLINO, M.D., LAKSHMI WABER, M.D., and YASSER KHAZAAL, M.D. Geneva, Switzerland 2 October 2008 http://ajp.psychiatryonline.org/cgi/conten...l/165/10/1357-a American Journal of Psychiatry Am J Psychiatry 165:1357-a-1358, October 2008 doi: 10.1176/appi.ajp.2008.08040618 © 2008 American Psychiatric Association Letter to the Editor To the Editor: While the correlations between schizophrenia and cannabis abuse are well corroborated, evidence for a causal correlation remains lacking. In their study, published in the April 2008 issue of the Journal, Monica Rais, M.D., et al. (1) found a more pronounced brain volume re…
Last reply by grace, -
- 0 replies
- 787 views
Cannabis, the FDA, and the Broken System of Pharmaceutical Research 1 October 2008 PR Cannazine http://pr.cannazine.co.uk/content/view/701/27/ Medical marijuana advocates often hear that marijuana can’t be a real medicine because it hasn’t been approved by the FDA. One common response to this is that the Drug Enforcement Administration continues to block the only avenue that could produce the research needed to seek FDA approval for medical marijuana, over a year and half after an administrative law judge ruled that the project should go ahead. But that’s just the start. The Journal of the American Medical Association recently published a scathing critique of th…
Last reply by grace, -
- 0 replies
- 1.6k views
I stumbled on this a while back and found it quite interesting. I for one understand the issues from social exclusion, and now work hard to educate others about it. I believe it still has relevence. Cannabis, social control and exclusion: the importance of social ties International Journal of Drug Policy Volume 12, Issues 5-6, 1 November 2001, Abstract This article analyzes psychosocial issues related to social exclusion created by the illegality of cannabis. The paper is divided into three parts. First, it provides a historical portrait of the penal approach to this social exclusion while focusing on the main recommendations of various international commissions in res…
Last reply by Smokin Moose,
